The purpose of this study is to find out how the language of people with Primary Progressive
Aphasia is affected by Propranolol. Propranolol is not FDA approved for the treatment of
Primary Progressive Aphasia. Propranolol is FDA approved for the treatment of heart
conditions such as blood pressure.
This research is being done because there are currently no drug treatment options for
language impairments and anxiety often experienced by people with Primary Progressive
Aphasia.